Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.28 USD | +1.13% | -6.18% | -27.44% |
08/05 | Olema Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02/04 | Goldman Sachs Initiates Olema Pharmaceuticals at Buy With $24 Price Target | MT |
- Stock Market
- Equities
- OLMA Stock
- News Olema Pharmaceuticals, Inc.
- MarketScreener Strategies